**Headline:** Global Anti-Obesity Drugs Market Projected to Reach $196 Billion by 2036 Driven by GLP-1 Therapies
The anti-obesity drugs market is expected to grow significantly, reaching an estimated value of $195.99 billion by 2036. This expansion is largely attributed to the increased clinical adoption of GLP-1 therapies, which have demonstrated improved efficacy in weight management. Additionally, growing recognition of obesity as a chronic medical condition is …